IP Library › Granted Patent US 12,097,215
Granted Patent B2
US 12,097,215 · App. 18/100,225 · Granted Sep 24, 2024

Antibacterial composition and its use in treating bacterial infections

Inventors: Peter Y. Novak (Sunny Isles Beach, FL); Maxim V. Temnikov (Miami, FL); Oleksandr Balakin (Dnepropetrovsk, UA)
Assignee: Vector Vitale IP LLC
A61K33/30A61K8/19A61K9/0053A61K9/06A61K33/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,097,215
App. No.
18/100,225
Granted
Sep 24, 2024
Kind
B2
Abstract

An antibacterial composition that comprises as active compound at least one light isotope of an element selected from the group which consists of 1 H, 12 C, 16 O, 14 N, 39 K, 24 Mg, 64 Zn, 85 Rb, 28 Si, 54 Fe, 92 Mo, 74 Se, 58 Ni, 70 Ge, 52 Cr, 63 Cu, 50 V, or combinations thereof, wherein the composition is enriched for the at least one light isotope. A method of treating and preventing bacterial diseases in humans and non-human animals by administering the composition. The use of the said composition in human and veterinary medicine for the prevention and treatment of diseases in humans and non-human animals and also as an antiseptic and disinfectant.

Claims (4)

1. A method of treating a condition that is caused by or characterized by a bacterial infection or excessive bacterial growth, wherein the method comprises administering an antibacterial composition comprising a bacteriostatic or bactericidal effective amount of at least one light isotope-enriched element selected from the group consisting of Si that is at least 95% 28 Si; K that is at least 98% 39 K; Mg that is at least 95 24 Mg, Rb that is at least 90% 85 Rb; Mo that is at least 80% 92 Mo; Se that is at least 50% 74 Se; Ge that is at least 90% 70 Ge; Cr that is at least 90% 52 Cr; Fe that is at least 80% 54 Fe; Ni that is at least 90% 58 Ni; Cu that is at least 90% 63 Cu; and V that is at least 35% 50V, wherein the light isotope-enriched element is present in elemental form or in the form of a pharmaceutically acceptable salt, compound or complex thereof, to said person or said veterinary mammal.

2. The method of claim 1 , wherein the condition is acne.

3. The method of claim 1 , wherein the condition is sepsis.

4. The method of claim 1 , wherein the condition is a bacterial infection.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2023
From: BALAKIN, OLEKSANDR
To: NOVAK, PETER Y.; TEMNIKOV, MAXIM V.
Reel/Frame 063140/0236 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2023
From: NOVAK, PETER Y.; TEMNIKOV, MAXIM V.
To: VECTOR VITALE IP LLC
Reel/Frame 063140/0432 →
Continuity (3)
Continuation 16210790 · Dec 5, 2018
Division 15486026 · Apr 12, 2017
Related Publication 20230218665A1 · Jul 13, 2023
Cited By (1)
US 12,734,240